[{"words": [{"word": "业绩", "head": 2, "tag": "n", "deprels": "SBV", "no": 0}, {"word": "变动", "head": 3, "tag": "v", "deprels": "ATT", "no": 1}, {"word": "原因", "head": 4, "tag": "n", "deprels": "SBV", "no": 2}, {"word": "说明", "head": 0, "tag": "v", "deprels": "HED", "no": 3}, {"word": "1", "head": 14, "tag": "m", "deprels": "ADV", "no": 4}, {"word": "、", "head": 14, "tag": "wp", "deprels": "WP", "no": 5}, {"word": "报告期", "head": 8, "tag": "n", "deprels": "ATT", "no": 6}, {"word": "内", "head": 14, "tag": "nd", "deprels": "ADV", "no": 7}, {"word": "，", "head": 8, "tag": "wp", "deprels": "WP", "no": 8}, {"word": "公司", "head": 11, "tag": "n", "deprels": "SBV", "no": 9}, {"word": "主营", "head": 12, "tag": "v", "deprels": "ATT", "no": 10}, {"word": "产品", "head": 13, "tag": "n", "deprels": "ATT", "no": 11}, {"word": "结构", "head": 14, "tag": "n", "deprels": "SBV", "no": 12}, {"word": "优化", "head": 4, "tag": "v", "deprels": "VOB", "no": 13}, {"word": "调整", "head": 14, "tag": "v", "deprels": "VOB", "no": 14}, {"word": "，", "head": 14, "tag": "wp", "deprels": "WP", "no": 15}, {"word": "主导", "head": 18, "tag": "n", "deprels": "ATT", "no": 16}, {"word": "产品", "head": 19, "tag": "n", "deprels": "SBV", "no": 17}, {"word": "抗", "head": 21, "tag": "v", "deprels": "ATT", "no": 18}, {"word": "病毒", "head": 19, "tag": "n", "deprels": "VOB", "no": 19}, {"word": "口服液", "head": 27, "tag": "n", "deprels": "ATT", "no": 20}, {"word": "和", "head": 25, "tag": "c", "deprels": "LAD", "no": 21}, {"word": "橘红", "head": 24, "tag": "b", "deprels": "ATT", "no": 22}, {"word": "系列", "head": 25, "tag": "n", "deprels": "ATT", "no": 23}, {"word": "产品", "head": 21, "tag": "n", "deprels": "COO", "no": 24}, {"word": "销售", "head": 27, "tag": "v", "deprels": "ATT", "no": 25}, {"word": "收入", "head": 30, "tag": "n", "deprels": "SBV", "no": 26}, {"word": "及", "head": 29, "tag": "c", "deprels": "LAD", "no": 27}, {"word": "利润", "head": 27, "tag": "n", "deprels": "COO", "no": 28}, {"word": "持续", "head": 14, "tag": "v", "deprels": "COO", "no": 29}, {"word": "稳健", "head": 32, "tag": "a", "deprels": "ADV", "no": 30}, {"word": "增长", "head": 30, "tag": "v", "deprels": "COO", "no": 31}], "sentence": "业绩变动原因说明1、报告期内，公司主营产品结构优化调整，主导产品抗病毒口服液和橘红系列产品销售收入及利润持续稳健增长"}]